Hispanic Patients Have Highest Survival Rate After Merkel Cell Carcinoma
Patients with MCC may have different sites of disease, stage at diagnosis, and survival outcomes according to their racial or ethnic group.
Patients with MCC may have different sites of disease, stage at diagnosis, and survival outcomes according to their racial or ethnic group.
The FDA has granted accelerated approval to Zynyz (retifanlimab) for the treatment of adults with metastatic or recurrent locally advanced Merkel cell carcinoma.
SBRT did not improve the efficacy of nivolumab-ipilimumab in patients with advanced Merkel cell carcinoma in a phase 2 study.
Risk of stage-specific Merkel cell carcinoma (MCC) recurrence and mortality over time since diagnosis is estimated.